• 09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care

  • Dec 12 2023
  • Length: 47 mins
  • Podcast

09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care

  • Summary

  • In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

    In Part II: Progressive Research and the Future of Care, guests dive deeper into the results of their recently published clinical trial outlining a novel drug combination for GVHD prevention, address the importance of ongoing communication, and take a look at how research is continuing to progress to promote a new standard of care.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less

What listeners say about 09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.